Legal & General Group Plc - ANTARES PHARMA INC ownership

ANTARES PHARMA INC's ticker is ATRS and the CUSIP is 036642106. A total of 82 filers reported holding ANTARES PHARMA INC in Q1 2016. The put-call ratio across all filers is - and the average weighting 0.1%.

Quarter-by-quarter ownership
Legal & General Group Plc ownership history of ANTARES PHARMA INC
ValueSharesWeighting
Q1 2022$270,000
+14.9%
65,7510.0%0.00%
Q4 2021$235,000
-1.3%
65,751
+0.6%
0.00%
Q3 2021$238,000
+58.7%
65,341
+89.8%
0.00%
Q2 2021$150,000
+24.0%
34,427
+16.7%
0.00%
Q1 2021$121,000
+34.4%
29,493
+30.1%
0.00%
Q4 2020$90,000
+38.5%
22,671
-4.8%
0.00%
Q3 2020$65,000
-23.5%
23,824
-22.7%
0.00%
Q2 2020$85,000
+25.0%
30,806
+5.5%
0.00%
Q1 2020$68,000
-60.7%
29,208
-20.8%
0.00%
Q4 2019$173,000
+69.6%
36,870
+20.7%
0.00%
Q3 2019$102,000
+1.0%
30,5540.0%0.00%
Q2 2019$101,000
+23.2%
30,554
+13.7%
0.00%
Q1 2019$82,000
+18.8%
26,873
+6.5%
0.00%
Q4 2018$69,000
-5.5%
25,244
+16.6%
0.00%
Q3 2018$73,000
+30.4%
21,6570.0%0.00%
Q2 2018$56,000
-1.8%
21,657
-16.4%
0.00%
Q1 2018$57,000
-24.0%
25,894
-30.7%
0.00%
Q4 2017$75,000
-38.0%
37,3890.0%0.00%
Q3 2017$121,000
+0.8%
37,389
-0.1%
0.00%
Q2 2017$120,000
+380.0%
37,430
+31.9%
0.00%
Q1 2016$25,000
-28.6%
28,3810.0%0.00%
Q4 2015$35,000
-27.1%
28,3810.0%0.00%
Q3 2015$48,000
-12.7%
28,381
+9.4%
0.00%
Q2 2015$55,000
+10.0%
25,931
+38.7%
0.00%
Q1 2015$50,000
+2.0%
18,6930.0%0.00%
Q4 2014$49,000
+40.0%
18,6930.0%0.00%
Q3 2014$35,00018,6930.00%
Other shareholders
ANTARES PHARMA INC shareholders Q1 2016
NameSharesValueWeighting ↓
Stonepine Capital Management, LLC 3,130,192$12,834,0005.32%
Velan Capital Investment Management LP 1,346,971$5,523,0005.12%
FIRST WILSHIRE SECURITIES MANAGEMENT INC 2,799,953$11,480,0004.03%
Sargent Investment Group, LLC 3,663,275$15,019,0003.78%
PERKINS CAPITAL MANAGEMENT INC 481,483$1,974,0001.62%
Rubric Capital Management LP 10,900,000$44,690,0001.62%
ORACLE INVESTMENT MANAGEMENT INC 1,720,000$7,052,0001.39%
Long Focus Capital Management, LLC 540,000$2,214,0000.28%
OBERWEIS ASSET MANAGEMENT INC/ 344,200$1,411,0000.28%
FIRETHORN WEALTH PARTNERS, LLC 84,069$345,0000.26%
View complete list of ANTARES PHARMA INC shareholders